Evidence map›Paper›PMID 38219146›Full record

ArticleCell reports2024

DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors.

Daria Ostroverkhova, Kathrin Tyryshkin, Annette K Beach, Elizabeth A Moore, Yosef Masoudi-Sobhanzadeh, Stephanie R Barbari, Igor B Rogozin, Konstantin V Shaitan, Anna R Panchenko, Polina V Shcherbakova

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Integrating evidence from protein domains to identify cancer driver mutations.Protein science : a publication of the Protein Society · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Daria OstroverkhovaDepartment of Pathology and Molecular Medicine, School of Medicine, Queen's University, Kingston, ON, Canada.
Kathrin TyryshkinDepartment of Pathology and Molecular Medicine, School of Medicine, Queen's University, Kingston, ON, Canada.
Annette K BeachEppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Elizabeth A MooreEppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Yosef Masoudi-SobhanzadehDepartment of Pathology and Molecular Medicine, School of Medicine, Queen's University, Kingston, ON, Canada.
Stephanie R BarbariEppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
Igor B RogozinNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Konstantin V ShaitanLomonosov Moscow State University, Moscow, Russia.
Anna R PanchenkoDepartment of Pathology and Molecular Medicine, School of Medicine, Queen's University, Kingston, ON, Canada. Electronic address: anna.panchenko@queensu.ca.
Polina V ShcherbakovaEppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address: pshcherb@unmc.edu.
Queen's University · CAUniversity of Nebraska Medical Center · USLomonosov Moscow State University · RUNational Institutes of Health · US

Funding

CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
Translesion Synthesis DNA Polymerases and Genome InstabilityR01ES015869 · NIEHS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SHCHERBAKOVA, POLINA V · 2009 to 2023
$4.7M
Mechanisms of Genome Instability in Tumors with DNA Polymerase Epsilon MutationsR01CA239688 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SHCHERBAKOVA, POLINA V · 2020 to 2024
$2.3M
NCI NIH HHS R01 CA239688NCI NIH HHS T32 CA009476NIEHS NIH HHS R01 ES015869
6 · The paper itself

Abstract

Alterations in the exonuclease domain of DNA polymerase ε cause ultramutated cancers. These cancers accumulate AGA>ATA transversions; however, their genomic features beyond the trinucleotide motifs are obscure. We analyze the extended DNA context of ultramutation using whole-exome sequencing data from 524 endometrial and 395 colorectal tumors. We find that G>T transversions in POLE-mutant tumors predominantly affect sequences containing at least six consecutive purines, with a striking preference for certain positions within polypurine tracts. Using this signature, we develop a machine-learning classifier to identify tumors with hitherto unknown POLE drivers and validate two drivers, POLE-E978G and POLE-S461L, by functional assays in yeast. Unlike other pathogenic variants, the E978G substitution affects the polymerase domain of Pol ε. We further show that tumors with POLD1 drivers share the extended signature of POLE ultramutation. These findings expand the understanding of ultramutation mechanisms and highlight peculiar mutagenic properties of polypurine tracts in the human genome.

Indexed as

Colorectal NeoplasmsDNA Polymerase IIDNA Polymerase IIIExome SequencingHumansMutagenesisMutationPoly-ADP-Ribose Binding ProteinsDNA Polymerase IIDNA Polymerase IIIPoly-ADP-Ribose Binding Proteinscolorectal cancerCP: CancerDNA polymerase deltaDNA polymerase epsilonendometrial cancermutationPOLD1POLEpolypurine tractstumor classificationVUS

Identifiers

PMID38219146
PMCPMC10830898
OpenAlexW4390810714

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.